US Stock MarketDetailed Quotes

NKGN NKGEN BIOTECH

Watchlist
  • 0.510
  • +0.110+27.56%
Trading Oct 21 11:56 ET
18.12MMarket Cap-134P/E (TTM)

NKGEN BIOTECH Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
-81.92%77K
0
3K
Operating revenue
--0
--0
--0
--0
--0
--0
--0
-81.92%77K
--0
--3K
Cost of revenue
0
0
0
-40.00%18K
15K
0
Gross profit
0
0
0
-85.10%59K
-15K
3K
Operating expense
12.80%7.46M
12.11%7.62M
21.88%29.75M
51.03%9.43M
15.15%6.9M
6.61M
6.8M
9.65%24.41M
6.25M
6M
Selling and administrative expenses
70.61%4.37M
37.07%4.39M
83.81%14.08M
147.50%5.34M
58.70%2.97M
--2.56M
--3.2M
0.98%7.66M
--2.16M
--1.87M
-General and administrative expense
70.61%4.37M
37.07%4.39M
83.81%14.08M
147.50%5.34M
58.70%2.97M
--2.56M
--3.2M
0.98%7.66M
--2.16M
--1.87M
Research and development costs
-23.78%3.09M
-10.09%3.24M
-6.44%15.67M
0.10%4.09M
-4.66%3.93M
--4.05M
--3.6M
14.14%16.75M
--4.09M
--4.12M
Operating profit
-12.80%-7.46M
-12.11%-7.62M
-22.18%-29.75M
-50.67%-9.43M
-15.20%-6.9M
-6.61M
-6.8M
-11.37%-24.35M
-6.26M
-5.99M
Net non-operating interest income expense
-943.55%-647K
-5,188.24%-1.8M
67.69%-745K
28.90%-438K
66.82%-211K
-62K
-34K
-75.36%-2.31M
-616K
-636K
Non-operating interest expense
943.55%647K
3,044.12%1.07M
-67.69%745K
-28.90%438K
-66.82%211K
--62K
--34K
75.36%2.31M
--616K
--636K
Total other finance cost
----
--729K
----
----
----
----
----
----
----
----
Other net income (expense)
-578.91%-7.98M
370.94%4.04M
-55,116.84%-52.46M
-36,406.15%-23.73M
-39,996.92%-26.06M
-1.18M
-1.49M
-13.10%-95K
-65K
-65K
Gain on sale of security
-522.29%-7.98M
--4.53M
---48.2M
---23.73M
---24.48M
---1.28M
----
----
----
----
Special income (charges)
----
----
---3.33M
--0
---3.33M
----
----
--0
--0
--0
-Less:Restructuring and merger&acquisition
----
----
--3.33M
--0
--3.33M
----
----
--0
--0
--0
Other non- operating income (expenses)
----
66.64%-497K
-871.58%-923K
--0
2,778.46%1.74M
--107K
---1.49M
-13.10%-95K
---65K
---65K
Income before tax
-104.97%-16.09M
35.33%-5.38M
-210.12%-82.95M
-384.07%-33.6M
-395.70%-33.18M
-7.85M
-8.32M
-14.99%-26.75M
-6.94M
-6.69M
Income tax
0
0.00%7K
0.00%7K
0
0
40.00%7K
7K
0
Net income
-104.97%-16.09M
35.33%-5.38M
-210.06%-82.95M
-383.68%-33.61M
-395.70%-33.18M
-7.85M
-8.32M
-15.00%-26.75M
-6.95M
-6.69M
Net income continuous Operations
-104.97%-16.09M
35.33%-5.38M
-210.06%-82.95M
-383.68%-33.61M
-395.70%-33.18M
---7.85M
---8.32M
-15.00%-26.75M
---6.95M
---6.69M
Minority interest income
Net income attributable to the parent company
-104.97%-16.09M
35.33%-5.38M
-210.06%-82.95M
-383.68%-33.61M
-395.70%-33.18M
-7.85M
-8.32M
-15.00%-26.75M
-6.95M
-6.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-104.97%-16.09M
35.33%-5.38M
-210.06%-82.95M
-383.68%-33.61M
-395.70%-33.18M
-7.85M
-8.32M
-15.00%-26.75M
-6.95M
-6.69M
Basic earnings per share
-86.85%-0.67
2.06%-0.25
-555.62%-5.38
-688.33%-1.68
-1,108.06%-2.48
-0.3586
-0.2553
-15.00%-0.8206
-0.2131
-0.2053
Diluted earnings per share
-86.85%-0.67
2.06%-0.25
-555.62%-5.38
-688.33%-1.68
-1,108.06%-2.48
-0.3586
-0.2553
-15.00%-0.8206
-0.2131
-0.2053
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000-81.92%77K03K
Operating revenue --0--0--0--0--0--0--0-81.92%77K--0--3K
Cost of revenue 000-40.00%18K15K0
Gross profit 000-85.10%59K-15K3K
Operating expense 12.80%7.46M12.11%7.62M21.88%29.75M51.03%9.43M15.15%6.9M6.61M6.8M9.65%24.41M6.25M6M
Selling and administrative expenses 70.61%4.37M37.07%4.39M83.81%14.08M147.50%5.34M58.70%2.97M--2.56M--3.2M0.98%7.66M--2.16M--1.87M
-General and administrative expense 70.61%4.37M37.07%4.39M83.81%14.08M147.50%5.34M58.70%2.97M--2.56M--3.2M0.98%7.66M--2.16M--1.87M
Research and development costs -23.78%3.09M-10.09%3.24M-6.44%15.67M0.10%4.09M-4.66%3.93M--4.05M--3.6M14.14%16.75M--4.09M--4.12M
Operating profit -12.80%-7.46M-12.11%-7.62M-22.18%-29.75M-50.67%-9.43M-15.20%-6.9M-6.61M-6.8M-11.37%-24.35M-6.26M-5.99M
Net non-operating interest income expense -943.55%-647K-5,188.24%-1.8M67.69%-745K28.90%-438K66.82%-211K-62K-34K-75.36%-2.31M-616K-636K
Non-operating interest expense 943.55%647K3,044.12%1.07M-67.69%745K-28.90%438K-66.82%211K--62K--34K75.36%2.31M--616K--636K
Total other finance cost ------729K--------------------------------
Other net income (expense) -578.91%-7.98M370.94%4.04M-55,116.84%-52.46M-36,406.15%-23.73M-39,996.92%-26.06M-1.18M-1.49M-13.10%-95K-65K-65K
Gain on sale of security -522.29%-7.98M--4.53M---48.2M---23.73M---24.48M---1.28M----------------
Special income (charges) -----------3.33M--0---3.33M----------0--0--0
-Less:Restructuring and merger&acquisition ----------3.33M--0--3.33M----------0--0--0
Other non- operating income (expenses) ----66.64%-497K-871.58%-923K--02,778.46%1.74M--107K---1.49M-13.10%-95K---65K---65K
Income before tax -104.97%-16.09M35.33%-5.38M-210.12%-82.95M-384.07%-33.6M-395.70%-33.18M-7.85M-8.32M-14.99%-26.75M-6.94M-6.69M
Income tax 00.00%7K0.00%7K0040.00%7K7K0
Net income -104.97%-16.09M35.33%-5.38M-210.06%-82.95M-383.68%-33.61M-395.70%-33.18M-7.85M-8.32M-15.00%-26.75M-6.95M-6.69M
Net income continuous Operations -104.97%-16.09M35.33%-5.38M-210.06%-82.95M-383.68%-33.61M-395.70%-33.18M---7.85M---8.32M-15.00%-26.75M---6.95M---6.69M
Minority interest income
Net income attributable to the parent company -104.97%-16.09M35.33%-5.38M-210.06%-82.95M-383.68%-33.61M-395.70%-33.18M-7.85M-8.32M-15.00%-26.75M-6.95M-6.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -104.97%-16.09M35.33%-5.38M-210.06%-82.95M-383.68%-33.61M-395.70%-33.18M-7.85M-8.32M-15.00%-26.75M-6.95M-6.69M
Basic earnings per share -86.85%-0.672.06%-0.25-555.62%-5.38-688.33%-1.68-1,108.06%-2.48-0.3586-0.2553-15.00%-0.8206-0.2131-0.2053
Diluted earnings per share -86.85%-0.672.06%-0.25-555.62%-5.38-688.33%-1.68-1,108.06%-2.48-0.3586-0.2553-15.00%-0.8206-0.2131-0.2053
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data